Table 2.
Vaccine-type serotype distribution of nasopharyngeal carriage of S. pneumoniae.
| Serotype | Proportion (95% CI) | Total no. of samples being serotyped | No. of samples of each serotype | No. of included studies | I2 | P | References |
|---|---|---|---|---|---|---|---|
| 1 | 0% (0%, 0%) | 1986 | 5 | 5 | 7.86% | 0.36 | 23,24,34, 35, 36 |
| 3 | 0% (0%, 1%) | 1986 | 10 | 5 | 0.00% | 0.42 | 23,24,34, 35, 36 |
| 4 | 0% (0%, 0%) | 1861 | 3 | 4 | 0.00% | 0.48 | 24,34, 35, 36 |
| 5 | 0% (0%, 0%) | 1861 | 0 | 4 | 0.00% | 0.88 | 24,34, 35, 36 |
| 6A | 23% (14%, 31%) | 1769 | 446 | 3 | 93.86% | <0.01 | 34, 35, 36 |
| 6B | 15% (12%, 18%) | 1769 | 253 | 3 | 65.49% | 0.06 | 34, 35, 36 |
| 7F | 0% (0%, 0%) | 1769 | 0 | 3 | 0.00% | 0.86 | 34, 35, 36 |
| 9V | 0% (0%, 1%) | 1945 | 9 | 4 | 31.51% | 0.22 | 32,34, 35, 36 |
| 14 | 8% (5%, 10%) | 2572 | 153 | 9 | 83.85% | <0.01 | 23,24,28,30, 31, 32,34, 35, 36 |
| 18C | 0% (0%, 0%) | 1769 | 3 | 3 | 0.00% | 0.37 | 34, 35, 36 |
| 19A | 3% (1%, 5%) | 2085 | 82 | 5 | 93.57% | <0.01 | 30,32,34, 35, 36 |
| 19F | 17% (12%, 21%) | 2177 | 377 | 6 | 83.46% | <0.01 | 30, 31, 32,34, 35, 36 |
| 23F | 10% (7%, 13%) | 2177 | 240 | 6 | 74.22% | <0.01 | 30, 31, 32,34, 35, 36 |
Note: I2, I-squared index for heterogeneity; P, P value for heterogeneity.